Hantavirus 2026

Experimental Antiviral Favipiravir Shipped to Europe for Hantavirus Outbreak Response; US Cruise Passengers Allowed Home Quarantine

Source: cidrap.umn.edu·2026-05-29Read original →
TL;DR
  • · Emergency shipments of experimental antiviral favipiravir (1,400 tablets) dispatched to France, Netherlands, and Spain to treat hantavirus cases from MV Hondius cruise ship
  • · European Commission launching emergency procurement to secure additional doses; favipiravir identified as most promising candidate under clinical-trial and compassionate-use protocols
  • · US officials permitting American MV Hondius passengers to quarantine at home starting June 1 with mandatory 24/7 monitoring outside residences for final three weeks of six-week quarantine period
The European Commission announced emergency shipments of the experimental antiviral favipiravir to France, the Netherlands, and Spain in response to hantavirus cases linked to the MV Hondius cruise ship. Fujifilm Pharmaceuticals donated 1,400 tablets; the European Medicines Agency identified favipiravir as the most promising candidate for clinical-trial and compassionate-use treatment, as no approved hantavirus drugs or vaccines currently exist. The EC is launching emergency procurement to secure additional doses if cases continue. Concurrently, US health officials announced that American passengers from the affected cruise ship may leave a Nebraska quarantine facility and return home beginning June 1, contingent on individual state deployment of 24/7 monitors outside their residences during the final three weeks of their mandatory six-week quarantine period.

Related

Country trackers
→ MV Hondius cruise ship outbreak hub
More coverage

This is an AI-generated summary. For full reporting, read the original at cidrap.umn.edu →